|
Newsbrief:
Israeli
Company
Receives
Notice
of
Allowance
from
US
Patent
Office
for
Synthetic
Marijuana
Pharmaceuticals
6/20/03
courtesy NORML News, http://www.norml.org
The Israeli-based Pharmos
pharmaceutical company announced last week that it has received a Notice
of Allowance from the US Patent and Trademark Office for a patent application
relating to the use of the company's synthetic marijuana derivative Dexanabinol
in the treatment of stroke, anti-inflammatory diseases and other disorders.
The company is presently
in the patient-recruitment phase of a US Phase III trial on the effectiveness
of Dexanabinol for the treatment of Traumatic Brain Injury (TBI).
A previous Phase II trial by Pharmos of 67 Israeli patients found that
Dexanabinol reduced mortality and eased intracranial pressure in subjects
suffering from severe head injuries.
Similar synthetic marijuana
derivatives have been effective in preclinical models in the treatment
of a variety of disorders, including "inflammatory disorders, neurodegenerative
disorders, brain ischemia, autoimmune diseases and pain," a Pharmos press
release stated.
According to a 1999 report
by the National Academy of Sciences' Institute of Medicine, naturally occurring
cannabinoids in marijuana also provide symptomatic relief for a number
of indications, including AIDS, cancer and chronic pain. Authors
of the study further noted that marijuana's neuroprotective qualities are
the "most prominent" of its potential therapeutic applications.
-- END --
|
Issue #292, 6/20/03
DRCNet
Needs Your Help |
Editorial:
No Drug War Exception to Good and Evil |
The Gathering
in Cartagena: The Global Social Forum Thematic Meeting on Democracy,
Human Rights, War, and the Drug Trade |
DRCNet
Interview: Nancy Obregón, Sub-Secretary General of the Confederation
of Peruvian Coca Growers |
DRCNet
Interview: Anthropologist Anthony Henman |
Dozens
of Students to Embark This Weekend on 50-Mile "Skate for Justice" |
Newsbrief:
12 Tulia Victims Walk Out of Jail |
No
Rockefeller Reform This Session |
Candidate
Dean Bending on Medical Marijuana |
Newsbrief:
RAVE Act Reverberations |
Newsbrief:
Teachers Against Prohibition Reborn as Educators for Sensible Drug Policy |
Newsbrief:
Kentucky Supreme Court Tightens Law on Methamphetamine Prosecutions |
Newsbrief:
Thais Get Drug War Help from US |
Newsbrief:
US-Peru Anti-Drug Flights Set to Resume |
Newsbrief:
Israeli Company Receives Notice of Allowance from US Patent Office for
Synthetic Marijuana Pharmaceuticals |
Teen
Facing 26 Years for First-Time Marijuana Offense Sentenced to Two |
Marc Mauer
Testimony on Comparative International Rates of Incarceration |
The Reformer's Calendar
|
This issue -- main page
This issue -- single-file printer version
Drug War Chronicle -- main page
Chronicle archives
|
PERMISSION to reprint or
redistribute any or all of the contents of Drug War Chronicle (formerly The Week Online with DRCNet is hereby
granted. We ask that any use of these materials include proper credit and,
where appropriate, a link to one or more of our web sites. If your
publication customarily pays for publication, DRCNet requests checks
payable to the organization. If your publication does not pay for
materials, you are free to use the materials gratis. In all cases, we
request notification for our records, including physical copies where
material has appeared in print. Contact: StoptheDrugWar.org: the Drug Reform Coordination Network,
P.O. Box 18402, Washington, DC 20036, (202) 293-8340 (voice), (202)
293-8344 (fax), e-mail [email protected]. Thank
you.
Articles of a purely
educational nature in Drug War Chronicle appear courtesy of the DRCNet
Foundation, unless otherwise noted.
|
